V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006408 | 10004230 | 1.65 | 70.2 | Palliative (P) | 2017-07-05 | 2017-07-05 | CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN | N | N | 10419141 | IBRUTINIB |
| 10006409 | 10007210 | 1.59 | 66 | Palliative (P) | null | 2016-11-09 | Bevacizumab | N | N | 10419266 | FLUOROURACIL |
| 10006410 | 10008940 | 1.69 | 87.65 | Palliative (P) | 2016-05-22 | 2016-06-13 | Carboplatin + Vinorelbine IV | N | N | 10420074 | PEMETREXED |
| 10006411 | 10004234 | 1.74 | 80.8 | Palliative (P) | 2017-09-03 | 2017-10-29 | LENALIDOMIDE | N | N | 10420074 | FLUOROURACIL |
| 10006412 | 10004235 | 1.71 | 85.5 | Disease modification (D) | null | 2018-02-04 | BENDAMUSTINE + RITUXIMAB | N | N | 10420888 | BENDAMUSTINE + RITUXIMAB |
| 10006413 | 10004235 | 1.72 | 66.7 | Curative (C) | 2018-05-02 | 2018-05-02 | CARBOPLATIN + PACLITAXEL | N | N | 10420888 | CARBOPLATIN + PACLITAXEL |
| 10006414 | 10004235 | 1.6 | 74.5 | Adjuvant (A) | 2017-03-24 | 2017-03-25 | Bevacizumab | 02 | N | 10420888 | GEMCARBO |
| 10006415 | 10004235 | 1.7 | 92 | Adjuvant (A) | 2018-01-13 | 2018-04-10 | CARBOPLATIN + PACLITAXEL | N | N | 10420888 | CARBOPLATIN + PACLITAXEL |
| 10006416 | 10004235 | 1.83 | null | Palliative (P) | 2015-09-26 | 2015-10-10 | Temozolomide 200mg/m2 | N | N | 10420888 | TEMOZOLOMIDE |
| 10006417 | 10009303 | null | 80.7 | Disease modification (D) | 2017-08-26 | 2017-08-28 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10426834 | CTD |
| 10006418 | 10004237 | 1.63 | 84.2 | Palliative (P) | 2018-01-28 | 2018-05-14 | Abiraterone | N | N | 10426874 | LENALIDOMIDE |
| 10006419 | 10004238 | 1.76 | 77.3 | Palliative (P) | 2018-02-11 | 2018-04-08 | Carboplatin + Pemetrexed | 02 | N | 10426874 | IBRUTINIB |
| 10006420 | 10004239 | 1.49 | 63.5 | Palliative (P) | 2017-07-09 | 2017-07-10 | Capecitabine | N | N | 10427051 | CAPECITABINE |
| 10006421 | 10004242 | 1.66 | 100 | Palliative (P) | 2018-04-02 | 2018-09-24 | null | N | N | 10427255 | IBRUTINIB |
| 10006422 | 10004242 | 1.7 | 65 | Disease modification (D) | 2018-02-28 | 2018-02-28 | Pemetrexed | N | N | 10427255 | GEMCARBO |
| 10006423 | 10008444 | null | 59.95 | Palliative (P) | 2017-10-12 | 2017-11-15 | Temozolomide 200mg/m2 | Y | N | 10427310 | TEMOZOLOMIDE |
| 10006424 | 10004244 | 1.67 | 101.6 | Palliative (P) | 2018-03-22 | 2018-03-25 | Capecitabine | 02 | N | 10427387 | CAPECITABINE |
| 10006425 | 10004244 | null | 71 | Palliative (P) | 2018-07-07 | 2018-07-15 | Temozolomide 150mg/m2 | N | null | 10427387 | TEMOZOLOMIDE |
| 10006426 | 10004245 | 1.63 | 85 | Palliative (P) | 2015-01-22 | 2015-02-07 | CARBOPLATIN + VINORELBINE | N | N | 10427504 | BEVACIZUMAB |
| 10006427 | 10004247 | null | null | Palliative (P) | null | 2015-10-08 | CARBOPLATIN + ETOPOSIDE | N | N | 10427506 | CARBOPLATIN + ETOPOSIDE |
| 10006428 | 10004248 | 1.87 | 80 | Palliative (P) | 2017-08-05 | 2018-01-26 | Carboplatin + Etoposide IV 3 day | 02 | N | 10427521 | CARBOPLATIN + ETOPOSIDE |
| 10006429 | 10007216 | 1.68 | 75.6 | Neo-adjuvant (N) | 2018-12-30 | 2019-01-07 | Capecitabine | N | Y | 10427521 | CAPECITABINE |
| 10006430 | 10004251 | 1.7 | 80.7 | Neo-adjuvant (N) | 2015-09-28 | 2015-09-29 | FLUOROURACIL + FOLINIC ACID | 02 | N | 10427557 | GEMCITABINE |
| 10006431 | 10004252 | 1.76 | 82 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-15 | Abiraterone | 02 | N | 10427597 | BEVACIZUMAB |
| 10006432 | 10007217 | 1.7 | null | null | 2016-09-02 | 2016-11-10 | Temozolomide 150mg/m2 | N | N | 10427597 | TEMOZOLOMIDE |
| 10006433 | 10007218 | null | null | Adjuvant (A) | 2015-09-18 | 2015-12-01 | LENALIDOMIDE | N | N | 10427636 | BEVACIZUMAB |
| 10006434 | 10004255 | 1.78 | 93 | Adjuvant (A) | 2018-06-26 | 2018-07-05 | Trial Unspecified | 02 | N | 10427683 | TRIAL |
| 10006435 | 10004256 | 1.65 | 107.7 | Palliative (P) | 2018-06-06 | 2018-10-25 | Fluorouricil + Folonic Acid (MdG) | N | N | 10427689 | ABIRATERONE |
| 10006436 | 10007219 | 1.76 | 88 | Palliative (P) | 2017-10-11 | 2017-10-16 | FLUOROURACIL | N | N | 10427777 | CARBOPLATIN + PEMETREXED |
| 10006437 | 10004258 | 1.77 | 85.7 | Palliative (P) | 2017-03-03 | 2017-03-08 | Carboplatin + Etoposide IV 3 day | 2 | N | 10427777 | CARBOPLATIN + ETOPOSIDE |
| 10006438 | 10004258 | 1.8 | 81.8 | Palliative (P) | 2018-08-23 | 2018-09-02 | Carboplatin + Vinorelbine IV &PO D8 | N | N | 10427777 | NOT MATCHED |
| 10006439 | 10004260 | 1.71 | 72.2 | Palliative (P) | 2017-11-13 | 2017-12-04 | BCG Intravesical | N | N | 10428159 | PEMETREXED |
| 10006440 | 10004261 | null | 78.5 | Palliative (P) | 2016-11-27 | 2016-11-28 | Capecitabine | 02 | N | 10428386 | CAPECITABINE |
| 10006441 | 10004261 | 1.76 | 83 | Disease modification (D) | 2017-01-03 | 2017-01-03 | GEMCITABINE | N | N | 10428386 | PEMETREXED |
| 10006442 | 10004262 | 1.56 | 85.8 | Palliative (P) | 2018-11-04 | 2018-11-14 | Trial Unspecified | 02 | N | 10428609 | TRIAL |
| 10006443 | 10004263 | 1.8 | 93.8 | Palliative (P) | 2015-12-05 | 2016-04-04 | Bendamustine+Rituximab(Sub Courses) | N | N | 10428712 | BENDAMUSTINE + RITUXIMAB |
| 10006444 | 10004263 | 1.72 | 109 | Palliative (P) | 2018-08-08 | 2018-08-29 | Carboplatin + Pemetrexed | N | N | 10428712 | LENALIDOMIDE |
| 10006445 | 10004265 | 0 | 89 | Palliative (P) | 2013-05-24 | 2013-05-24 | CTD | 02 | N | 10428728 | CARBOPLATIN |
| 10006446 | 10004266 | 1.63 | 83.1 | Palliative (P) | 2018-02-25 | 2018-03-09 | Carboplatin + Etoposide IV 3 day | N | Y | 10428728 | CARBOPLATIN + ETOPOSIDE |
| 10006447 | 10004267 | 1.78 | 67.8 | Curative (C) | 2015-07-08 | 2015-07-09 | Abiraterone | 02 | N | 10428877 | FLUOROURACIL |
| 10006448 | 10004268 | 1.65 | 70.3 | Adjuvant (A) | 2016-06-06 | 2016-06-27 | Carboplatin + Vinorelbine IV | N | N | 10428946 | BCG |
| 10006449 | 10004269 | 1.64 | 62.7 | Not known (9) | 2016-08-25 | 2016-08-25 | TEMOZOLOMIDE | N | N | 10428951 | TEMOZOLOMIDE |
| 10006450 | 10004269 | 1.7 | null | Adjuvant (A) | 2015-12-21 | 2016-04-18 | CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN | N | N | 10428951 | GEMCARBO |
| 10006451 | 10004272 | 1.76 | 58 | Palliative (P) | 2019-07-09 | 2019-07-12 | Carboplatin + Etoposide iv&po | 2 | N | 10428956 | CARBOPLATIN + ETOPOSIDE |
| 10006452 | 10007226 | 1.79 | 81.5 | Palliative (P) | 2018-10-19 | 2018-10-25 | LENALIDOMIDE | 02 | N | 10429010 | LENALIDOMIDE |
| 10006453 | 10004274 | 1.82 | 123.4 | Curative (C) | 2016-11-26 | 2016-11-26 | GemCarbo Days 1+8 | N | N | 10429043 | ABIRATERONE |
| 10006454 | 10007227 | 1.8 | 91.4 | null | 2016-04-03 | 2016-04-19 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | 10429063 | CVP R |
| 10006455 | 10004275 | null | 67.7 | c | 2016-05-04 | 2016-05-10 | CARBOPLATIN + VINORELBINE | 2 | N | 10429368 | LENALIDOMIDE |
| 10006456 | 10004277 | 1.87 | null | Palliative (P) | 2016-01-17 | 2016-01-18 | LENALIDOMIDE | N | N | 10429369 | GEMCITABINE |
| 10006457 | 10004278 | 1.87 | 0 | Neo-adjuvant (N) | 2017-03-14 | 2017-09-27 | Trial Unspecified | N | N | 10429369 | TRIAL |